147 related articles for article (PubMed ID: 417993)
41. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K
Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574
[TBL] [Abstract][Full Text] [Related]
42. Natural history study of glycan accumulation in large animal models of GM2 gangliosidoses.
Cavender C; Mangini L; Van Vleet JL; Corado C; McCullagh E; Gray-Edwards HL; Martin DR; Crawford BE; Lawrence R
PLoS One; 2020; 15(12):e0243006. PubMed ID: 33259552
[TBL] [Abstract][Full Text] [Related]
43. Molecular forms of beta-N-acetylhexosaminidase in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with Tay-Sachs disease.
Salvayre R; Maret A; Negre A; Lenoir G; Vuillaume M; Icart J; Didier J; Douste-Blazy L
Eur J Biochem; 1983 Jul; 133(3):627-33. PubMed ID: 6305653
[TBL] [Abstract][Full Text] [Related]
44. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
Charrow J; Binns HJ
Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
[TBL] [Abstract][Full Text] [Related]
45. Cultured skin fibroblasts in lipidoses. Enzymatic, histochemical, and ultrastructural relationship in Fabry's Tay-Sachs, and Sandhoff's diseases.
Yuasa T; Fukuma M; Takashima S; Takaki R
Arch Pathol Lab Med; 1980 Jun; 104(6):321-7. PubMed ID: 6246846
[TBL] [Abstract][Full Text] [Related]
46. In situ assessment of beta-hexosaminidase activity.
Lacorazza HD; Jendoubi M
Biotechniques; 1995 Sep; 19(3):434-40. PubMed ID: 7495557
[TBL] [Abstract][Full Text] [Related]
47. Characterization and tissue distribution of N-acetyl hexosaminidase C: suggestive evidence for a separate hexosaminidase locus.
Swallow DM; Evans L; Saha N; Harris H
Ann Hum Genet; 1976 Jul; 40(1):55-66. PubMed ID: 9025
[TBL] [Abstract][Full Text] [Related]
48. Human recombinant lysosomal β-Hexosaminidases produced in Pichia pastoris efficiently reduced lipid accumulation in Tay-Sachs fibroblasts.
Espejo-Mojica AJ; Rodríguez-López A; Li R; Zheng W; Alméciga-Díaz CJ; Dulcey-Sepúlveda C; Combariza G; Barrera LA
Am J Med Genet C Semin Med Genet; 2020 Dec; 184(4):885-895. PubMed ID: 33111489
[TBL] [Abstract][Full Text] [Related]
49. Steroid hexosaminidase activity in Tay-Sachs and Sandhoff-Jatzkewitz diseases.
Tomasi LG; Fukushima DK; Kolodny EH
Neurology; 1974 Dec; 24(12):1158-65. PubMed ID: 4280528
[No Abstract] [Full Text] [Related]
50. Characterization of polypeptides serologically and structurally related to hexosaminidase in cultured fibroblasts.
Tsui F; Mahuran DJ; Lowden JA; Mosmann T; Gravel RA
J Clin Invest; 1983 Apr; 71(4):965-73. PubMed ID: 6833496
[TBL] [Abstract][Full Text] [Related]
51. Synthesis of beta-hexosaminidase in cell-free translation and in intact fibroblasts: an insoluble precursor alpha chain in a rare form of Tay-Sachs disease.
Proia RL; Neufeld EF
Proc Natl Acad Sci U S A; 1982 Oct; 79(20):6360-4. PubMed ID: 6959123
[TBL] [Abstract][Full Text] [Related]
52. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
Harzer K
Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344
[No Abstract] [Full Text] [Related]
53. Correction of I-cell defect by hybridization with lysosomal enzyme deficient human fibroblasts.
d'Azzo A; Halley DJ; Hoogeveen A; Galjaard H
Am J Hum Genet; 1980 Jul; 32(4):519-28. PubMed ID: 6772024
[TBL] [Abstract][Full Text] [Related]
54. The lysosomal hexosaminidase isozymes.
Mahuran D; Novak A; Lowden JA
Isozymes Curr Top Biol Med Res; 1985; 12():229-88. PubMed ID: 3886595
[TBL] [Abstract][Full Text] [Related]
55. Complementation of genetic disease: a velocity sedimentation procedure for the enrichment of heterokaryons.
Hohmann LK; Shows TB
Somatic Cell Genet; 1979 Nov; 5(6):1013-29. PubMed ID: 545716
[TBL] [Abstract][Full Text] [Related]
56. Human hexosaminidase isozymes. III. Distribution and activity of isozymes in peripheral blood leukocytes and platelets.
Nakagawa S; Kumin S; Fox D; Nitowsky HM
J Lab Clin Med; 1978 Jun; 91(6):922-8. PubMed ID: 650058
[TBL] [Abstract][Full Text] [Related]
57. Diagnosing Lysosomal Storage Disorders: The GM2 Gangliosidoses.
Hall P; Minnich S; Teigen C; Raymond K
Curr Protoc Hum Genet; 2014 Oct; 83():17.16.1-8. PubMed ID: 25271840
[TBL] [Abstract][Full Text] [Related]
58. Characterization of residual hexosaminidase activity in Sandhoff's disease using man-Chinese hamster cell hybrids.
Hoeksema HL; Reuser AJ; Hoogeveen AT; Westerveld A; Galjaard H
Hum Genet; 1977 Dec; 39(3):315-9. PubMed ID: 413781
[TBL] [Abstract][Full Text] [Related]
59. Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?
Rosengren B; Månsson JE; Svennerholm L
J Neurochem; 1987 Sep; 49(3):834-40. PubMed ID: 3612128
[TBL] [Abstract][Full Text] [Related]
60. Unusual thermolability properties of leukocyte beta-hexosaminidase: implications in screening for carriers of Tay-Sachs disease.
Prence EM; Natowicz MR; Zalewski I
Clin Chem; 1993 Sep; 39(9):1811-4. PubMed ID: 8375052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
